Providing evidence-based information in a practical, easy-to-read format for practicing clinicians, investigators, industry scientists, and other entities involved in the field of neuroscience
Current Issue • July–September 2024
Executive Functioning in Children and Adolescents with ADHD and Disruptive Behavior Disorders
by Rosa Elena Ulloa Flores, MD, PhD; Ricardo Díaz Sánchez, BS; Francisco R. de la Peña, MD, MS; Marcos F. Rosetti Sciutto, PhD; Lino Palacios Cruz, MD, PhD; and Pablo Mayer Villa, MD, MS Dr. Ulloa [...]
Olfactory Dysfunction in Incidental Lewy Body Disease and Parkinson’s Disease: An Update
by Shemonti Hasan, MD; Charles H. Adler, MD, PhD; Nan Zhang, MS; Geidy E. Serrano, PhD; Lucia I. Sue, BS; Holly A. Shill, MD; Shyamal H. Mehta, MD, PhD; Thomas G. Beach, MD, PhD; and Erika D. [...]
Impact of COVID-19 Pandemic on Psychiatric Patients at Clinical Trial Sites
by Maria Fe Garcia-Rada, MPS, and Robert E. Litman, MD Ms. Garcia-Rada and Dr. Litman are with CenExel CBH Health in Gaithersburg, Maryland. Dr. Litman is with Georgetown University Medical School in Washington, DC. Funding: [...]
Stroop Test for Parkinson’s Disease with Deep Brain Stimulation: A Systematic Review
by Amer Cavalheiro Hamdan, PhD, and Mariana Drabik Vieira, MSc Dr. Hamdan is with the Graduate Program in Psychology, Department of Psychology, Federal University of Parana in Curitiba, Brazil. Dr. Vieira is a psychologist, candidate [...]
Psychotherapy for Adult ADHD
by Kari Harper, MD, and Julie P. Gentile, MD, MBA Dr. Harper is Assistant Professor and Dr. Gentile is Professor and Chair of the Department of Psychiatry at Wright State University in Dayton, Ohio. Funding: [...]
Play Therapy via Telemedicine in a Child with Sudden-onset Emotional Disorder During the COVID-19 Lockdown Period: A Case Report
by Swapnajeet Sahoo, MD; Diksha Sachdeva, MPhil; Sana Yumnam, MD; Ruchita Shah, MD; Aseem Mehra, MD; and Sandeep Grover, MD All authors are with the Department of Psychiatry, Post Graduate Institute of Medical Education and [...]
Xanomeline and Trospium: A Potential Fixed Drug Combination (FDC) for Schizophrenia—A Brief Review of Current Data
by Alok Singh, MD Dr. Singh is with All India Institute of Medical Sciences in Raipur, India. Funding: No funding was provided for this study. Disclosures: The author has no conflicts of interest relevant to [...]
Virtual and Augmented Reality-based Treatments for Phantom Limb Pain: A Systematic Review
by Andrew Yimu Vassantachart, MD; Elizabeth Yeo, MD; and Brian Chau, MD Dr. Vassantachart is with Loma Linda University School of Medicine in Loma Linda, California. Dr. Yeo is with the Department of Physical Medicine [...]
Past Articles
How Should Therapists Treat Patients who are so Altruistic They Regularly Harm Themselves for the Sake of Others?
by Edmund Howe, MD, JD Dr. Howe is Professor of Psychiatry and Professor of Medicine, Uniformed Services University of the Health Sciences in Bethesda, Maryland. Department Editor: Julie P. Gentile, MD, is Professor and Chair [...]
Urdu Adaptation and Validation of Social Interaction Anxiety Scale: A Confirmatory Factor Analysis
by Uzma Ilyas, PhD scholar, and Prof. Dr. Saima Dawood, PhD Ms. Ilyas is with the Centre for Clinical Psychology, University of the Punjab. Prof. Dr. Dawood is Director, Centre for Clinical Psychology, University of [...]
GLP-1 Agonists Can Affect Mood: A Case of Worsened Depression on Ozempic (Semaglutide)
by Senthil Vel Rajan Rajaram Manoharan, MD, and Rohit Madan, MD Dr. Manoharan is with Huntsville Hospital/University of Alabama at Birmingham – Huntsville Campus in Huntsville, Alabama. Dr. Madan is with University of Arizona College [...]
The Impact of High-density Lipoprotein Cholesterol (HDL-C) Levels and Risk of Movement Disorders in Patients Taking Antipsychotics
by CAROLYN O’DONNELL, PharmD; TAMMIE LEE DEMLER, BS, PharmD, MBA, BCGP, BCPP; EILEEN TRIGOBOFF, RN, PMHCNS-BC, DNS, DABFN; and CLAUDIA LEE, MD Dr. O’Donnell is with Edward Hines Jr. Veterans Administration Hospital in Hines, Illinois, [...]
Risk Management: EHR Use and Emerging Risks
by Justin A. Pope, JD Mr. Pope is a Senior Risk Manager at Professional Risk Management Services (PRMS). FUNDING: No funding was provided for the preparation of this article. DISCLOSURES: The author is an employee [...]
Letter to the Editor: The Catastrophic Perception of Pain in Burning Mouth Syndrome May be Associated with Sympathetic Tone as Indicated by the QTc Interval
Innov Clin Neurosci. 2024;21(1–3):8–9. Funding/financial disclosures. The authors have no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Dear Editor: Unexplained somatic symptoms [...]
Artificial Intelligence and Neurorehabilitation: Fact vs. Fiction
by Nicola Fiorente, MD; Sepehr Mojdehdehbaher, BSc; and Rocco Salvatore Calabrò, MD, PhD Dr. Fiorente is with Polimedica Fisio and Sport in Cittadella (PD), Italy. Dr. Mojdehdehbaher is with Engineering Department, University of Messina in [...]
Impact of COVID-19 Pandemic on Patients with Serious Mental Illness (SMI) and Nonpsychiatric Control Subjects in Clinical Trials
by Maria Fe Garcia-Rada, MPS, and Robert E. Litman, MD Ms. Fe Garcia-Rada and Dr. Litman are with CenExel CBH Health in Gaithersburg, Maryland. Dr. Litman is additionally with Georgetown University Medical School in Washington, [...]